Ken Coyle
Keine laufenden Positionen mehr
Profil
Ken Coyle served as the Chief Executive Officer at Genactis, Inc. He also worked as the Senior Director-Respiratory Biologics Marketing at AstraZeneca PLC and as the Vice President-Sales at Radius Health, Inc. Coyle holds a graduate degree from Rutgers State University of New Jersey and an undergraduate degree from Grinnell College.
Ehemalige bekannte Positionen von Ken Coyle
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Vertrieb & Marketing | - |
| Genactis, Inc. | Vorstandsvorsitzender | - |
| RADIUS HEALTH, INC. | Vertrieb & Marketing | - |
Ausbildung von Ken Coyle
| Rutgers State University of New Jersey | Graduate Degree |
| Grinnell College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
| Genactis, Inc. |
